Cargando...
Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancer
PURPOSE: The aim of this study was to evaluate the therapeutic efficacy and safety of trastuzumab emtansine (T-DM1) for the treatment of patients with human epidermal growth factor receptor 2-positive breast cancer. METHODS: We performed a systemic review and meta-analysis of the relevant published...
Gardado en:
| Publicado en: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4778787/ https://ncbi.nlm.nih.gov/pubmed/27013890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S100499 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|